-
1 Comment
Chongqing Pharscin Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 5.4% below its 200 day moving average.
From a valuation standpoint, the stock is 36.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.1.
Chongqing Pharscin Pharmaceutical Co., Ltd's total revenue rose by 11.0% to $245M since the same quarter in the previous year.
Its net income has dropped by 30.0% to $32M since the same quarter in the previous year.
Finally, its free cash flow fell by 96.7% to $1M since the same quarter in the previous year.
Based on the above factors, Chongqing Pharscin Pharmaceutical Co., Ltd gets an overall score of 2/5.
| Exchange | SHE |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| CurrencyCode | CNY |
| ISIN | CNE100003308 |
| Beta | -0.24 |
|---|---|
| Market Cap | 6B |
| PE Ratio | 93.73 |
| Target Price | None |
| Dividend Yield | 0.6% |
Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. The company was founded in 1996 and is headquartered in Chongqing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002907.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
